Jagsonpal Pharmaceuticals Overview

  • Year Founded
  • 1978

Year Founded

  • Status
  • Public

  • Employees
  • 1,305

Employees

  • Stock Symbol
  • 507789

Stock Symbol

  • Investments
  • 5

  • Share Price
  • $2.30
  • (As of Friday Closing)

Jagsonpal Pharmaceuticals General Information

Description

Jagsonpal Pharmaceuticals Ltd is a pharmaceutical company engaged in the manufacturing and trading of pharmaceutical formulations and active pharmaceutical ingredients (APIs). Its portfolio covers therapeutic areas including Gynaecology, Orthopaedics, Dermatology and Paediatrics, with Gynaecology and Orthopaedics forming its core areas of focus. The company offers a range of pharmaceutical formulations, and its brands include Lycored, Maintane, Doxypal DR, Indocap and others.

Contact Information

Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Corporate Office
  • Plot No. 412-415, Nimai Tower, 3rd Floor
  • Phase IV, Udyog Vihar, Sector-18
  • Gurugram, Haryana 122015
  • India
+91 0124
Primary Industry
Pharmaceuticals
Stock Exchange
BOM
Vertical(s)
Corporate Office
  • Plot No. 412-415, Nimai Tower, 3rd Floor
  • Phase IV, Udyog Vihar, Sector-18
  • Gurugram, Haryana 122015
  • India
+91 0124

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jagsonpal Pharmaceuticals Stock Performance

As of 13-Nov-2026, Jagsonpal Pharmaceuticals’s stock price is $2.30. Its current market cap is $152M with 66.1M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.30 $2.32 $1.69 - $2.79 $152M 66.1M 12.6K $0.07

Jagsonpal Pharmaceuticals Financials Summary

As of 30-Sep-2026, Jagsonpal Pharmaceuticals has a trailing 12-month revenue of $34.1M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 152,867 114,365 159,371 76,119
Revenue 34,055 32,505 31,779 25,210
EBITDA 7,602 6,343 8,421 2,865
Net Income 4,874 4,876 6,547 2,713
Total Assets 33,135 33,563 32,530 26,031
Total Debt 959 865 1,080 1,072
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Jagsonpal Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Jagsonpal Pharmaceuticals‘s full profile, request access.

Request a free trial

Jagsonpal Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Jagsonpal Pharmaceuticals Ltd is a pharmaceutical company engaged in the manufacturing and trading of pharmaceutical for
Pharmaceuticals
Gurugram, India
1,305 As of 2026

Mumbai, India
 

Hyderabad, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Jagsonpal Pharmaceuticals Competitors (17)

One of Jagsonpal Pharmaceuticals’s 17 competitors is Evonile Pharma, a Private Equity-Backed company based in Mumbai, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Evonile Pharma Private Equity-Backed Mumbai, India
Dr. Reddy's Corporation Hyderabad, India
Sun Pharmaceutical Industries Corporation Mumbai, India
Novartis Corporation Basel, Switzerland
GSK Corporation London, United Kingdom
You’re viewing 5 of 17 competitors. Get the full list »

Jagsonpal Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Jagsonpal Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Jagsonpal Pharmaceuticals‘s full profile, request access.

Request a free trial

Jagsonpal Pharmaceuticals Investments & Acquisitions (5)

Jagsonpal Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with Group Pharmaceuticals (Wellness Portfolio) for . The deal was made on 01-Oct-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Group Pharmaceuticals (Wellness Portfolio) 01-Oct-2026 Corporate Asset Purchase Buildings and Property
Aequitas Healthcare 07-Jul-2026 Buyout/LBO Pharmaceuticals
Resilient Cosmeceuticals 21-Feb-2025 Merger/Acquisition Pharmaceuticals
Yash Pharma (India and Bhutan Businesses) 01-Jun-2024 Merger/Acquisition Specialty Retail
Zingavita 11-Feb-2021 Seed Round Other Consumer Non-Durables
To view Jagsonpal Pharmaceuticals’s complete investments and acquisitions history, request access »

Jagsonpal Pharmaceuticals ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Jagsonpal Pharmaceuticals’s complete esg history, request access »

Jagsonpal Pharmaceuticals Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Aequitas Healthcare Mumbai, India 2017

Jagsonpal Pharmaceuticals FAQs

  • When was Jagsonpal Pharmaceuticals founded?

    Jagsonpal Pharmaceuticals was founded in 1978.

  • Where is Jagsonpal Pharmaceuticals headquartered?

    Jagsonpal Pharmaceuticals is headquartered in Gurugram, India.

  • What is the size of Jagsonpal Pharmaceuticals?

    Jagsonpal Pharmaceuticals has 1,305 total employees.

  • What industry is Jagsonpal Pharmaceuticals in?

    Jagsonpal Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Jagsonpal Pharmaceuticals a private or public company?

    Jagsonpal Pharmaceuticals is a Public company.

  • What is Jagsonpal Pharmaceuticals’s stock symbol?

    The ticker symbol for Jagsonpal Pharmaceuticals is 507789.

  • What is the current stock price of Jagsonpal Pharmaceuticals?

    As of 13-Nov-2026 the stock price of Jagsonpal Pharmaceuticals is $2.30.

  • What is the current market cap of Jagsonpal Pharmaceuticals?

    The current market capitalization of Jagsonpal Pharmaceuticals is $152M.

  • What is Jagsonpal Pharmaceuticals’s current revenue?

    The trailing twelve month revenue for Jagsonpal Pharmaceuticals is $34.1M.

  • Who are Jagsonpal Pharmaceuticals’s competitors?

    Evonile Pharma, Dr. Reddy's, Sun Pharmaceutical Industries, Novartis, and GSK are some of the 17 competitors of Jagsonpal Pharmaceuticals.

  • What is Jagsonpal Pharmaceuticals’s annual earnings per share (EPS)?

    Jagsonpal Pharmaceuticals’s EPS for 12 months was $0.07.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process